ASCO 2023: New drug combination twice as effective for some ovarian cancer patients as next best treatment 04 Jun 2023 A targeted drug combination for patients with a type of ovarian cancer could be nearly twice as effective as the next best treatment, according to interim results from a phase II study. Find out more Show/Hide
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein 03 Jun 2022 A drug combination targeting multiple mutant versions of cancer’s ‘death star’ protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer. Find out more Show/Hide
ESMO 2021: Drug combination shows promise in treatment-resistant advanced ovarian cancer 19 Sep 2021 A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial – shrinking tumours in half of patients. Find out more Show/Hide